January 19, 2017 Acad, Gov/Utilities Mass Spectrometry

Achieve High-Accuracy Analysis of Residual Pesticides in Foods with a Gas Chromatograph Mass Spectrometer Release of Smart Pesticides Database Ver. 2, a Database for Residual Pesticides in Foods

The consumption of health foods using herbal medicines and other plant materials is growing, particularly in the U.S. and Europe. As a result, the focus of measurement is expanding beyond fresh foods to include processed foods and supplements, and the development of analysis methods for residual pesticides in these foods is advancing. However, processed foods... Read more

August 31, 2016 Acad, Gov/Utilities Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships

Johns Hopkins and Salk Co-lead $15 Million Initiative to Unravel Bipolar Disorder and Schizophrenia

Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Cardiomyocytes iCell Cardiomyocytes2 iCell Cardiac Progenitor Cells iCell Neurons iCell Astrocytes iCell DopaNeurons iCell GlutaNeurons iCell Hepatocytes 2.0 iCell Hepatoblasts iCell Skeletal Myoblasts iCell Endothelial Cells... Read more

August 11, 2016 Acad, Gov/Utilities Product Launch

New ASTM D8045 – New method for acid number determination in crude oil

Metrohm is pleased to announce that the ASTM has published method D8045 for the determination of Acid Number (AN) in crude oil and petroleum products. The new method describes thermometric titration and was developed by Metrohm together with industry leaders using the 859 Titrotherm titrator. Method D8045 demonstrates the superiority of thermometric titration for complex... Read more

June 22, 2016 Acad, Gov/Utilities Cell Analysis Tools M&A, Partnerships

Cellular Dynamics and the National Eye Institute Establish a Cooperative Research and Development Agreement (CRADA) to Advance Cell Transplantation Therapy for the Treatment of Retinal Degenerative Disease using iPSC-Derived Cells

Cellular Dynamics and the National Eye Institute Establish a Cooperative Research and Development Agreement (CRADA) to Advance Cell Transplantation Therapy for the Treatment of Retinal Degenerative Disease using iPSC-Derived Cells – Cellular Dynamics International Read more

June 17, 2016 Acad, Gov/Utilities

Saving energy – an incentive for everyone

Greiner Bio-One GmbH has been recertified to DIN EN ISO 50001 and aims to continuously improve its energy efficiency. The energy management system at the Greiner Bio-One GmbH site in Frickenhausen has been certified to DIN EN ISO 50001 since 2013. The company, which is a technology partner to the diagnostic and pharmaceutical industry, recently... Read more

April 15, 2016 Acad, Gov/Utilities Bio/Pharma/CRO Molecular Spectroscopy

Jet fuel, crude oil, diesel blends: Quality control with NIR spectroscopy

Near-Infrared Spectroscopy (NIRS) enables straightforward multiparameter analysis of critical parameters for monitoring the refining of hydrocarbons. NIRS is a nondestructive secondary analysis method, NIRS does not require any handling of chemicals whatsoever, and real-time measurements are performed at the push of a button. NIRS is the ideal method for a wide range of applications: Distillation... Read more

October 5, 2015 Acad, Gov/Utilities

Leakwise Oil-on-Water Demo Video

Oct 5, 2015 – Boulder, CO – GE Analytical Instruments invites you to view the Leakwise Oil-on-Water Monitoring System demonstration video. In addition to an overview of the new SLC-220 Controller, this video reviews the capablities of various types of Leakwise Sensors for multiple applications and needs, as well as types of communication, and options that are available... Read more

September 24, 2015 Acad, Gov/Utilities Clinical Research/Diagn.

Precise Diagnosis for Precision Lung Cancer Drug: GE Healthcare’s Clarient Diagnostics Offering FDA approved PD-L1 companion diagnostic for Merck’s Keytruda®

California, USA – 2 October 2015 –  Clarient Diagnostic Services, Inc. a division of GE Healthcare (NYSE:GE) announced it will be offering the FDA approved PD-L1 companion diagnostic which will help identify patients most likely to benefit from Merck’s newly-approved lung cancer drug, Keytruda.   http://www.genewsroom.com/press-releases/precise-diagnosis-precision-lung-cancer-drug-ge-healthcare%E2%80%99s-clarient-diagnostics Read more